HAG
INSM icon

HighPoint Advisor Group’s Insmed INSM Stock Holding History

HighPoint Advisor Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,626
Closed -$457K – 843
2025
Q4 		$457K Sell
2,626
-226
-8% -$41.2K 0.01% 691
2025
Q3 		$411K Sell
2,852
-605
-18% -$74.1K 0.02% 440
2025
Q2 		$348K Buy
3,457
+193
+6% +$14.8K 0.02% 470
2025
Q1 		$233K Sell
3,264
-332
-9% -$25.4K 0.01% 566
2024
Q4 		$287K Buy
+3,596
New +$259K 0.02% 522

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

HighPoint Advisor Group's INSM Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Insmed (INSM) in Q1 2026, closing a stake of 2,626 shares — an estimated $457K sold.

HighPoint Advisor Group first reported a position in INSM in Q4 2024 and held it in 5 quarters. The position peaked at $457K in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • HighPoint Advisor Group reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 2,626 Insmed shares in Q1 2026, an estimated $457K.
  • HighPoint Advisor Group first reported a position in Insmed in Q4 2024 and held it in 5 quarters.
  • HighPoint Advisor Group's Insmed position peaked at $457K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.